Drug Trial Radar · NCT04849728
A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )
Last checked: Nov 19, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
1,000
Planned (sponsor's estimate)
Start
Aug 19, 2021
Primary completion
Sep 29, 2026
Study completion Sep 30, 2027
Sponsor
- Lead sponsor
- Inventiva PharmaIndustry
- Sponsor type
- Industry
- First posted
- Apr 19, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3
Conditions
- NASH - Nonalcoholic Steatohepatitis
Interventions
IVA337Drug
A total of 1000 patients will be randomised to receive lanifibranor (800 mg/day) or lanifibranor (1200 mg/day), or matching placebo, employing a 1:1:1 randomisation scheme, respectively, without interruption between Part A and Part B.
PlaceboDrug
A total of 1000 patients will be randomised to receive lanifibranor (800 mg/day) or lanifibranor (1200 mg/day), or matching placebo, employing a 1:1:1 randomisation scheme, respectively, without interruption between Part A and Part B.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Resolution of NASH and improvement of fibrosisTime frame: Part A: Date of randomisation until the date of biopsy at Week 72
- Safety AnalysesTime frame: 48 weeks after completion of DBPC period
Locations
459 sites in 24 countries. Site status is shown where the registry gives one.
Objective Health - Birmingham Gastroenterology Associates
Birmingham, Alabama
Digestive Health Specialist of the Southeast
Dothan, Alabama
North Alabama GI Research Center llc
Madison, Alabama
The Institute For Liver Health - Chandler
Chandler, Arizona
Arizona Liver Health - Peoria
Peoria, Arizona
Dignity Health - St. Joseph's Hospital and Medical Center
Phoenix, Arizona
Saint Joseph's Hospital and Medical Center
Phoenix, Arizona
Adobe Gastroenterology
Tucson, Arizona
Arizona Liver Health
Tucson, Arizona
ARcare Center for Clinical Research - Conway
Conway, Arkansas
ARcare Center for Clinical Research
Little Rock, Arkansas
Arkansas Diagnostic Center
Little Rock, Arkansas
Arkansas Gastroenterology
North Little Rock, Arkansas
Summit - Arkansas Gastroenterology
North Little Rock, Arkansas
Fomatmedicalresearch
Camarillo, California
GW Research
Chula Vista, California
Velocity Clinical Research, Chula Vista
Chula Vista, California
TriWest Research Associates
El Cajon, California
Cure Clinical Research, LLC
Fountain Valley, California
SC Clinical Research
Garden Grove, California
Velocity Clinical Research - Gardena
Gardena, California
National Research Institute - Santa Ana
Huntington Park, California
The Clinical Trials Network - Gastro Care Institute
Lancaster, California
National Research Institute - Westlake
Los Angeles, California
National Research Institute - Panorama City
Panorama City, California
California Liver Reearch
Pasadena, California
Cadena Care Institute
Poway, California
Stanford University Medical Center
Redwood City, California
Research and Education, Inc.
San Diego, California
California Pacific Medical Center Research Institute
San Francisco, California
Quest Clinical Research
San Francisco, California
Silicon Valley Research Institute
San Jose, California
Clinical Trial Management Services
Thousand Oaks, California
San Fernando Valley Health Institute
Van Nuys, California
South Denver Gastroenterology - Swedish Medical Center Office
Englewood, Colorado
Yale School of Medicine
New Haven, Connecticut
Synergy Healthcare
Bradenton, Florida
Florida Research Institute
Bradenton, Florida
Tampa Bay Medical Research
Clearwater, Florida
Gastro Florida
Clearwater, Florida
Showing 40 of 459 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.